Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes

BACKGROUND: Due to its neurotoxic properties, oligomeric alpha-synuclein (α-syn) has been suggested as an attractive target for passive immunization against Parkinson’s disease (PD). In mouse models of PD, antibody treatment has been shown to lower the levels of pathogenic α-syn species, including o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neuroinflammation
Auteurs principaux: Gustafsson, Gabriel, Lindström, Veronica, Rostami, Jinar, Nordström, Eva, Lannfelt, Lars, Bergström, Joakim, Ingelsson, Martin, Erlandsson, Anna
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725978/
https://ncbi.nlm.nih.gov/pubmed/29228971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1018-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires